Suchergebnisse
Tandem Diabetes Care Inc
WKN: A2H5BX / Name: Tandem Diabetes / Aktie / Ausrüstung & Versorgung / Mid Cap /
19,40 €
-5,45 %
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi
Key Points
- Interested in Tandem Diabetes Care, Inc.? Here are five stocks we like better.
- Tandem is shifting U.S. pump distribution to pharmacies through a pay-as-you-go model designed to
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say
Tandem Diabetes Care, Inc. (TNDM) reported $254.56 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 5.8%. EPS of -$0.31 for the same period compares to
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.48 per share a year ago
Tandem Diabetes Care Q2 Earnings Call Highlights
Key Points
- Interested in Tandem Diabetes Care, Inc.? Here are five stocks we like better.
- Record second-quarter performance: Worldwide sales rose 6% year over year to $255 million, while pump
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up
Tandem Diabetes Care, Inc. TNDM reported a second-quarter 2026 loss of 31 cents per share, narrower than the Zacks Consensus Estimate of a loss of 34 cents. The figure improved from the year-ago